SUMMARY Supravalvular aortic stenosis (McKusick 18550) is a rare hereditary condition with autosomal dominant transmission. However, the available data have been limited to small family groups which do not allow the definition of the degree of penetrance of the disease. The present study describes a large family with a high frequency of supravalvular aortic stenosis including five generations and 80 subjects, the largest family group with this disease studied so far. The study was carried out prospectively in 66 subjects (clinical examination, ECG, M mode and two dimensional echocardiography). In 14 subjects available data were examined retrospectively. In 10 patients cardiac catheterisation was performed (prospective study in eight).
The disease was present in 36 (45%) of the 80 subjects investigated, on the basis of clinical, echocardiographic, and haemodynamic (when available) criteria. The disease was found to be severe in eight cases (22%), moderate in six cases (17%), mild in 13 (36%), and undefined in eight (22%) patients. In one case (3%), multiple pulmonary stenoses were noted in the absence of supravalvular aortic stenosis. Genetic analysis of these data shows, for the first time, the degree of penetrance of the supravalvular aortic stenosis trait (K=0-86) and confirms that it is transmitted with incomplete penetrance and variable expressivity.
In 1964 Eisenberg et all described an infrequent familial form of supravalvular aortic stenosis (SVAS) without unusual facies or mental retardation. These observations were followed by a few reports of single pedigrees in which SVAS was identified in members of successive generations in a pattern consistent with autosomal dominant inheritance.2-9 Nevertheless, the genetic features of the syndrome remained incompletely defined owing to the difficulty in collecting an adequate number of cases. Echocardiography permits non-invasive, accurate, and direct visualisation of the supravalvular portion of the aorta. Furthermore, the recent availability of portable echocardiographic systems allows rapid evaluation of patients and screening of relatives in their homes, and thus makes it possible to perform large epidemiological studies.
In the present investigation, we have defined the patterns of genetic transmission of SVAS and its related vascular abnormalities in a large family group of 80 subjects. The purpose of this study was to define for the first time the penetrance and the expressivity of the phenotype of SVAS.
Received for publication 14 All echocardiographic examinations were performed by the same operator and included, as well as a standard approach, cross sectional imaging obtained with the patient in a left lateral position where inclination was clearest for observation in longitudinal section of the aortic valve and supravalvular tract complex.
Detection of obstruction comprised visualisation of the decrease in diameter of the vessel (fig 1) where this was greater than that usually found above the aortic root.12 Fifty-two examinations were carried out using a transportable OT1E Biomedica mechanical sector scanner with a 3*5 MHz transducer. This equipment made it possible to examine at home those family members in which a hospital evaluation was not feasible. Nine echocardiograms were obtained in our laboratory using an ATL Mark 300 mechanical sector scanner with a 3 MHz transducer. The videotaped echocardiograms were rerecorded on a Sony U-matic videotape VO-5800 PS and were reviewed in real time, slow motion, and frame by frame stop image by two independent observers who were unaware of each other's interpretations. Agreement between two observers was required for a diagnosis of SVAS and for the detection of associated abnormalities.
In two cases (2.9%) disagreement was resolved by consensus.
DIAGNOSTIC CRITERIA Diagnosis of SVAS was established by the presence of the following criteria. (1) Echocardiographic documentation of supravalvular aortic stenosis distal to the valvular cusps; and (2) systolic ejection murmur in the aortic area, radiating to the carotid arteries.
Furthermore, cardiac catheterisation, performed in 10 cases, showed the presence of a transaortic gradient in six of them. The degree of severity of SVAS was estimated according to the criteria given in table 1.
Diagnosis of pulmonary stenosis was based on the detection of angiographic features consistent with this abnormality. The presence of a systolic murmur in the pulmonic area was not considered diagnostic since the aortic origin of such a finding could not be excluded.
GENETIC STUDY
The family pedigree, covering five generations, is shown in fig 2. The estimate of the penetrance of the SVAS phenotype was made by calculating the proportion of affected offspring divided by half the total number of offspring, all sibships being included.13
Results

DIAGNOSIS OF SVAS
Data from affected subjects are reported in table 2. Chiarella et al   IV 19 , IV-29, and V-1). In one case (III-16) evidence of SVAS was based on the results of cardiac catheterisation and surgical repair. In three cases (11-3, III-9, and V-1) evidence of SVAS was based on the clinical diagnosis of aortic stenosis made by a cardiologist and the ECG evidence of LV hypertrophy. In another four cases (III-17, IV-18, IV 19, and IV-29), a history of sudden death in the first year of life was the only fact consistent with the presence of serious congenital heart disease. Finally, one of the founders of the family group studied must necessarily be considered a heterozygous carrier of the SVAS gene.
In three cases (III-11, III*20, and IV-32), the lack of adequate information made the diagnosis of the disease impossible, even on a retrospective basis.
Degree of severity of SVAS The degree of SVAS was estimated to be mild in 13 patients (36%), moderate in six (17%), and severe in eight (22%). In the remaining eight patients (22%) the degree of stenosis could not be determined.
MULTIPLE PULMONARY STENOSES
In five of the 10 patients who underwent cardiac catheterisation, multiple pulmonary stenoses were observed; in one case (IV.9) this abnormality was noted in the absence of SVAS. The degree of pulmonary stenosis on angiographic examination was defined as mild in two patients, moderate in two, and severe in one.
GENETIC EVALUATION
The large number of family members affected and the accuracy of the diagnostic approach made it possible to evaluate the gene segregation of SVAS. Transmission occurs through an autosomal dominant gene with incomplete penetrance (II4, II-6, III-7, III-8, and III-28) and variable expressivity (mild, moderate, or severe degree of stenosis).
Moreover, both sexes appear to be heterozygous for the SVAS gene without preferential selection. In fact, the features of the disease were present (second, third, and fourth generations) in 20 males and 13 females, even though the degree of aortic abnormality was different; three males and two females were unaffected carriers of the gene. The sex ratio (second, third, and fourth generations) for carriers of the SVAS gene is 1-5 (23 males and 15 females) and the male/female ratio is 1*2 (41 males and 35 females). Table 3 gives the penetrance coefficient calculation for the SVAS trait; there are four affected subjects out of seven in the second generation, 12 out of 27 in the third, and 17 out of 42 in the fourth, giving a total of 33 Genetic transmission of Williams' syndrome was described by Grimm and Wesselhoeft17 in their study of 128 families. For the Eisenberg form, however, only two studies have supplied an adequate number of cases: the first2 described three generations of a family with six members with SVAS; the second8 studied two generations of a family with six cases of SVAS.
In the family we studied, the characteristics of the Familial supravalvular aortic stenosis: a genetic study
Eisenberg form were present, including cases of SVAS, of multiple pulmonary stenoses, and of a combination of the two. The fact that the family have been island dwellers for several centuries, and are consequently endogamous, explains the unusually high number of patients studied. Although no consanguineous marriages have taken place over the last five generations, it can be assumed that this was not the case before. This supposition is based on information gathered from second generation family members, the General Registry, and local records. 10 According to Grimm and Wesselhoeft,17 both the Williams form and the Eisenberg form of SVAS may be found together in a single family, but none of our subjects suffered either from mental retardation or alteration of facial features.
Our cases would appear to conform entirely to the Eisenberg syndrome. The identity of this form of the disease, about which some doubt has recently been expressed,5 would seem, therefore, to be confirmed. Our family would certainly not appear to confirm the suggestion that all SVAS cases should be classified under Williams' syndrome.
Recent progress in the field of echocardiography has made a non-invasive assessment of SVAS possible, first through the use of the M mode technique1921 and later using the two dimensional system. 12 The reliability of this technique for qualitative and quantitative evaluation of SVAS has recently been shown by Vogt et al. 22 The two dimensional system enabled us to distinguish different degrees of aortic narrowing and to study all the members of the family group, thus making it possible to gather sufficient information for genetic evaluation. The Doppler examination, which might have given further information, was not available at the time of the study.
Weyman et a112 have pointed out that the ascending aorta may be of varying dimension in normal subjects,12 and therefore, in order to avoid false positive diagnoses where a mild stenosis was indicated echocardiographically, SVAS was considered present only when this narrowing was associated with a systolic ejection murmur recognised by two independent observers.
Out of the 10 patients who underwent haemodynamic examination, SVAS associated multiple pulmonary stenoses were found in four cases and isolated multiple pulmonary stenoses in one. Since only 13% of the family underwent this examination, the global incidence of this associated pathology might have been underestimated. However, in the absence of clinical indications for cardiac catheterisation, it was not considered ethically justifiable for research purposes only to refer other members of the family for an invasive procedure. Data could not be obtained from three subjects. This is probably of little importance, however, given the total number of cases studied.
Grimm and Wesselhoeft17 and other authors2 8 have already observed that the autosomal dominant Mendelian trait of SVAS is transmitted genetically with incomplete penetrance and variable expressivity of the phenotype. Until now, however, the penetrance coefficient has never been calculated. The present study confirms the type of Mendelian transmission, determines its expression with greater accuracy, and calculates the penetrance coefficient.
Conclusion
Our study confirms that SVAS is transmitted genetically and that the pattern of inheritance is consistent with an autosomal dominant trait with variable expressivity and penetrance. The penetrance coefficient calculated for this family is 0-86. The clinical picture, characterised by SVAS and multiple pulmonary stenoses, without mental retardation or other dysmorphic features, agrees with the form described by Eisenberg, is quite different 
